A core outcome set for trials evaluating self‐management interventions in people with severe mental illness and coexisting type 2 diabetes

Claire Carswell,Jo Taylor,Richard I. G. Holt,Jennifer V. E. Brown,Ramzi Ajjan,Jan R. Böhnke,Tim Doran,Ian Kellar,David Shiers,Judy Wright,Najma Siddiqi
DOI: https://doi.org/10.1111/dme.15288
IF: 3.5
2024-01-19
Diabetic Medicine
Abstract:Background People with severe mental illness (SMI), such as schizophrenia, have higher rates of type 2 diabetes and worse outcomes, compared to those without SMI and it is not known whether diabetes self‐management interventions are effective for people who have both conditions. Research in this area has been impeded by a lack of consensus on which outcomes to prioritise in people with co‐existing SMI and diabetes. Aims To develop a core outcome set (COS) for use in effectiveness trials of diabetes self‐management interventions in adults with both type 2 diabetes and SMI. Methods The COS was developed in three stages: (i) identification of outcomes from systematic literature review of intervention studies, followed by multi‐stakeholder and service user workshops; (ii) rating of outcomes in a two‐round online Delphi survey; (iii) agreement of final 'core' outcomes through a stakeholder consensus workshop. Results Seven outcomes were selected: glucose control, blood pressure, body composition (body weight, BMI, body fat), health‐related quality of life, diabetes self‐management, diabetes‐related distress and medication adherence. Conclusions This COS is recommended for future trials of effectiveness of diabetes self‐management interventions for people with SMI and type 2 diabetes. Its use will ensure trials capture important outcomes and reduce heterogeneity so findings can be readily synthesised to inform practice and policy.
endocrinology & metabolism
What problem does this paper attempt to address?